🔎 Trials Near Me

Domov › Metastatski rak › Indiana

Klinične študije za Metastatski rak v Indiana

25 študij za Metastatski rak išče udeležence na lokacijah v Indiana.

Mesta v Indiana

Uradno besedilo študije (angleško)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • UChicago Medicine Northwest Indiana, Crown Point
  • Woodland Cancer Care Center, Michigan City
Vključevanje udeležencevFaza 2
Vse starosti · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT05564377

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • IU Simon Cancer Center, Indianapolis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06465069

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

  • Research Site, Fort Wayne
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07205822

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT06625775

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Franciscan Health, Indianapolis
  • Franciscan Health Mooresville, Mooresville
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07222800

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

  • Community Health Network, Inc, Indianapolis
  • Community Health Network, Inc., Indianapolis
  • Community Health Network, Inc., Indianapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Indiana University Health University Hospital, Indianapolis
  • Deaconess GI Specialty Center, Newburgh
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07174336

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • Community Health Network, Indianapolis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06128551

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07213804

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

  • Community Health Network MD Anderson Cancer Center - North, Indianapolis
Vključevanje udeležencevFaza 1
Starost 18–99 · Vsi spoli · Posodobljeno 21. sep. 2026 · NCT07403721

Prospective Validation of a Points Score System Predicting 30-day Survival

  • IU Health West, Avon
  • IU Health North / Schwarz Cancer Center, Carmel
  • Methodist Hospital, Indianapolis
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT05100342

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
  • Franciscan Health, Indianapolis
  • in še 1
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 8. sep. 2026 · NCT06119581

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

  • Community Cancer Center North, Indianapolis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT07602842

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Northwest Cancer Center, Dyer
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 2. sep. 2026 · NCT06072612

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Indiana University (IU) Melvin and Bren Simon Cancer Center, Indianapolis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 20. avg. 2026 · NCT05614739

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

  • Community Health Network, Indianapolis
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 30. jul. 2026 · NCT04657068

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Fort Wayne
  • Research Site, Indianapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Ženske · Posodobljeno 29. jul. 2026 · NCT07044336

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

  • Parkview Packnett Family Cancer Institute, Fort Wayne
  • Franciscan Health Indianapolis, Indianapolis
Vključevanje udeležencevFaza 3
Starost 18 in več · Vsi spoli · Posodobljeno 25. jun. 2026 · NCT06216301

A Study of LY4175408 in Participants With Advanced Cancer

  • Community Health Network, Indianapolis
Vključevanje udeležencevFaza 1
Starost 18 in več · Vsi spoli · Posodobljeno 23. jun. 2026 · NCT07046923

Evaluating Disparities in Precision Oncology

  • Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
Vključevanje udeležencevOpazovalna študija
Starost 18 in več · Vsi spoli · Posodobljeno 16. jun. 2026 · NCT06081517

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
Vključevanje udeležencevFaza 2/3
Starost 18 in več · Moški · Posodobljeno 8. apr. 2026 · NCT04787744

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 1. apr. 2026 · NCT05735080

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

  • Northwest Cancer Centers, Dyer
Vključevanje udeležencevFaza 1/2
Starost 18 in več · Vsi spoli · Posodobljeno 18. mar. 2026 · NCT06244771

A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer

  • First Urology, Jeffersonville
Vključevanje udeležencevFaza 1
Starost 18 in več · Moški · Posodobljeno 4. feb. 2026 · NCT04729114

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.